CVS - Company ID 0000064803
The table below shows CVS HEALTH Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B |
| Cost of revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
CVS HEALTH Corp reported annual revenue of $402.07B for fiscal year 2025. That is up 7.8% from $372.81B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $177.55B (FY 2016) to $402.07B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B |
| Income tax | $408.00M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B |
| EPS (diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 |